Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.140
-0.500-2.83%
Volume:1.44M
Turnover:24.56M
Market Cap:17.60B
PE:-19.70
High:17.630
Open:17.460
Low:17.030
Close:17.640
52wk High:34.820
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:0.88
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.54
PE(LYR):-19.70
PS:4.98

Loading ...

Stock Track | Junshi Biosciences Soars 5.11% Intraday on Positive Clinical Data and Broker Upgrade

Stock Track
·
Apr 20

Stock Track | Junshi Bio Soars 5.01% Intraday on Anticipation of AACR Clinical Data for JS207 and JS212

Stock Track
·
Apr 17

Junshi Bio Shares Climb Over 3% Again as Investors Await AACR Data on JS207 and JS212

Stock News
·
Apr 17

Junshi Biosciences Sets 27 Apr 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express
·
Apr 15

Stock Track | Junshi Biosciences Soars 5.43% Intraday on Shareholder Confidence and Strong Revenue Growth

Stock Track
·
Apr 15

BNP PARIBAS SA Reduces Stake in Junshi Bio by 1.19 Million Shares at HK$26.18 Each

Stock News
·
Apr 14

Stock Track | Junshi Biosciences Soars 8.66% Intraday as Major Shareholder Holds Stake After Sale Plan Lapses

Stock Track
·
Apr 13

Junshi Biosciences' Shareholder Keeps Stake After Sale Plan Lapses; Shares Jump 5%

MT Newswires Live
·
Apr 13

Junshi Bio: 2% Share-Sale Plan by 5%+ Shareholder Expires Without Execution

Bulletin Express
·
Apr 10

JUNSHI BIO (01877) Announces Shareholder Shanghai Tanying Did Not Reduce Holdings

Stock News
·
Apr 10

AH Share Premium Rankings as of April 6

Stock News
·
Apr 06

AH Share Premium Rankings for April 3

Stock News
·
Apr 03

China International Capital Corp. Highlights Positive Trends in Domestic Innovative Drug Sector, Anticipates Key Academic Developments in 2026

Stock News
·
Apr 03

JUNSHI BIO: March 2026 Monthly Return Confirms Stable Share Capital and No Share Movements

Bulletin Express
·
Apr 02

AH Share Premium Rankings as of April 1

Stock News
·
Apr 01

BRIEF-Shanghai Junshi Biosciences Says From 12 April 2025 To 31 March 2026, Chair Increased Stake

Reuters
·
Apr 01

Junshi Bio Chairman Concludes RMB100.64 Million Share Purchase; Controlling Group Stake Rises to 18.24%

Bulletin Express
·
Mar 31

Shanghai Junshi Biosciences - From 12 April 2025 to 31 March 2026, Chairman Increased Stake of Co by 3.3 Mln a,H Shares for RMB100.6 Mln

THOMSON REUTERS
·
Mar 31

JUNSHI BIO Sees 28% Revenue Growth, Yet Struggles to Close Nearly 10-Billion-Yuan Loss Gap

Deep News
·
Mar 25

Is It Time To Reassess Shanghai Junshi Biosciences (SEHK:1877) After Its Recent Share Price Strength

Simply Wall St.
·
Mar 22